Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: J Gastrointest Cancer. 2012 Dec;43(4):562–569. doi: 10.1007/s12029-012-9368-3

Fig. 2.

Fig. 2

Overall survival by KRAS mutation status. Kaplan–Meier curve of overall survival of KRAS mutant and KRAS wild-type patients. HR=1.567; 95% CI: 0.396–6.20